Table 1 Patients characteristics at initial treatment and recurrence

Initial cancer

Age

26–83 (52)^a

FIGO stage

 1a

3

(3.6)

 1b1

12

(14.3)

 1b2

4

(4.7)

 1b3

4

(4.7)

 2a1

5

(6.0)

 2a2

2

(2.4)

 2b

10

(11.9)

 3a

2

(2.4)

 3b

3

(3.6)

 3c1

34

(40.4)

 3c2

5

(6.0)

Histology

 squamous

49

(58.3)

 adeno

24

(28.6)

 adenosquamous

5

(6.0)

Others

6

(7.1)

Primary treatment

 Ope

15

(17.9)

 Ope + RT

6

(7.1)

 Ope + CCRT

16

(19.0)

 Ope + Chemo

13

(15.5)

 RT

9

(10.7)

 CCRT

25

(29.8)

At recurrence

 Follow up interval

  1 months

46

(54.7)

  2 months

24

(28.6)

  3 > months

14

(16.7)

Recurrence site

 Local

19

(22.6)

 Pelvic LN

9

(10.7)

 Distal LN

14

(16.7)

 Distant metastasis

27

(32.1)

 Multipe metasitasis

15

(17.9)

Method of diagnosis

 Symptom

10

(11.9)

 Pap smear

13

(15.5)

 Tumor marker

19

(22.6)

 Imaging analysis

42

(50.0)